Previous Article | Next Article ![]()
Clinical and Diagnostic Laboratory Immunology, November 2002, p. 1392-1395, Vol. 9, No. 6
1071-412X/02/$04.00+0 DOI: 10.1128/CDLI.9.6.1392-1395.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Department of Microbiology, School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, New York 14214
Received 24 April 2002/ Returned for modification 17 July 2002/ Accepted 22 August 2002
|
|
|---|
|
|
|---|
Peripheral blood monocytes/macrophages were obtained from age-matched healthy adult donors and from patients diagnosed with MS who were in remission and not receiving medication. After 48 h in culture, the adherent cells were infected with HCoV strains 229E and OC43 at a multiplicity of 1 (3, 10). Both infectivity assays were done on the same day with pairs of normal and MS monocytes/macrophages. The HCoV strains used were obtained from the American Type Culture Collection (Manassas, Va.), plaque purified twice, and grown on L-132 (229E) or HRT-18 (OC43) cells. Infectious virus titers of samples were quantitated by the immunoperoxidase assay with antiviral monoclonal antibodies (MAb) to S (spike antigen), 1.10C.3 for HCoV strain OC43 and 5.11H.6 for HCoV strain 229E (15).
Cultures were harvested on days 1 and 2 postinfection (p.i.) and evaluated. HCoV strain 229E-infected blood monocytes/macrophages produced viral titers of 103.5 to 106 50% tissue culture-infective doses (TCID50)/ml, and HCoV strain OC43-infected cells only produced viral titers of 101.2 to 102.5 TCID50/ml (Fig. 1A and B). After HCoV strain 229E infection, the cells appeared pyknotic and granular, with swelling of the plasma membrane and a few syncytia at 16 to 18 h p.i. The number of syncytia did not increase with time. The titer and cytopathic effect were similar to those previously reported (10). HCoV strain OC43 infection proceeded without a cytopathic effect and at a low titer, comparable the amount of virus detected after 2 h of incubation at 4°C and two washes to remove the inoculum. In cultures kept for 6 days, the titer increased slightly to 102.7 TCID50/ml. Viability was comparable to that of uninfected controls. Previously, HCoV strain OC43 titers of 105.3 to 107.3 PFU/ml were obtained from umbilical cord blood monocytes/macrophages (3). For confirmation that the viral titers measured were indeed associated with infection of monocytes or macrophages, immunofluorescence microscopy was performed with MAb to S viral antigen. After blocking of Fc receptors with normal goat serum (DAKO, Carpinteria, Calif.), cells where stained for the viral S antigen expressed on the surface of paraformaldehyde (4%)-fixed cells. In cultures infected with HCoV strain 229E, the majority of cells (>55%) expressed viral antigen 2 days p.i., similar to earlier work (10). Following HCoV strain OC43 infection, very few cells (<5%) expressed viral antigen, compared to 15% of cord blood-derived monocytes/macrophages positive for viral nucleocapsid antigen (3) (Fig. 1C). This suggests that replication depends on the level of differentiation of these cells (6). Preferential viral replication in less differentiated tissues was observed with primary neurons derived from dorsal root ganglia and astrocyte cultures (1, 11). Healthy donors and MS patients gave similar responses within the parameters of our experiments.
![]() View larger version (41K): [in a new window] |
FIG. 1. Yield of infectious virus from HCoV-infected monocytes/macrophages derived from MS patients (lanes 1, 3, and 5) and healthy control subjects (lanes 2, 4, and 6). Panels A and B represent the same patients. Open bars: virus yields at 24 h p.i. Closed bars: virus yields at 48 h p.i. The virus titers after 2 h of incubation at 4°C and removal of the inoculum by two cell washings were 75 to 125 TCID50/ml. (A) HCoV strain 229E infections. (B) HCoV strain OC43 infections. The limit of detection was 25 TCID50/ml. (C) Detection of HCoV antigens by immunocytochemistry analysis of monocytes/macrophages infected for 48 h with an S antigen-specific MAb (5.11H.6 for 229E and 1.10C.3 for OC43). a and c are immunofluorescence images, b and d are phase-contrast images of the same field. a and b are 229E-infected cells; c and d are OC43-infected cells. Original magnification, x600.
|
|
View this table: [in a new window] |
TABLE 1. Susceptibility of monocytes/macrophages to apoptosis caused by HCoV
|
![]() View larger version (18K): [in a new window] |
FIG. 2. (A) Percentage of monocytes/macrophages showing apoptosis at the times indicated after infection with HCoV strain 229E. Apoptosis was measured by dual-parameter flow cytometry for annexin V-PE staining and DNA fluorescence with 7-AAD. Data are from six healthy donors; each case is a comparison of infected cells with mock-infected control cells. (B) Flow cytometry profiles of annexin V-PE+ 7-AAD- stained cells at 16 h p.i. Top, HCoV strain 229E-infected cells; middle, mock-infected cells; bottom, cellular autofluorescence.
|
A time-dependent expression of cell membrane HCoV strain 229E S antigen on monocytes/macrophages was observed (Fig. 3A). At 24 h p.i., 47% of the infected cells showed immunofluorescence. This compares well with a previous report that about half of the attached infected cells fluoresced (10). At 48 h p.i., a >0.5-log displacement increase in signal intensity for virus-specific MAb, compared to the isotype control MAb, was seen (Fig. 3B). The percentages of viable cells, as measured by trypan blue dye exclusion, were 75, 86, 52, and 34, respectively, at 1, 2, 3, and 4 days p.i., while the uninfected cells remained 82 to 90% viable throughout. Previously, 70% viability in the infected attached cells after 24 h was reported (10).
![]() View larger version (26K): [in a new window] |
FIG. 3. Flow cytometric analysis of cell surface expression of viral antigen. Monocyte/macrophage cultures were inoculated with HCoV strain 229E and labeled at various times with virus-specific MAb 5.11H.6 or an isotypic control antibody. (A) Percentage of cells having a fluorescence signal displacement above the cutoff established for unstained cells. (B) Flow cytometry profile of fluorescein isothiocyanate-labeled cells at 48 h p.i. Left profile, cellular autofluorescence; middle (dotted) profile, isotypic control; right profile, virus-specific MAb. (C) Percentage of viable cells having dual fluorescence for virus-specific MAb 5.11H.6 (fluorescein isothiocyanate positive) and annexin V (PE+). Error bars represent standard deviations of data from three donors.
|
Overall, the increase in apoptotic cells observed in HCoV strain 229E-infected cultures at 16 h p.i. was associated with few necrotic cells and in normal cultures, there were only 4 to 12% apoptotic cells. In the mock-infected cultures, some cells likely enter the apoptotic pathway of cell death. Monocytes normally circulate in the blood for only a few days, during which time they either migrate to tissues and differentiate to macrophages or die through apoptosis (12). Apoptosis caused by HCoV in adherent monocytes/macrophages in culture might then be due to commitment to proapoptotic signals generated by the virus. Possibly, production of cytokine mediators such as tumor necrosis factor alpha was also a factor since a difference was observed in the percent apoptosis at 16 h p.i. (47% versus 29%) between cells stained only with annexin V and cells both immunostained and annexin V stained (Fig. 2A and 3C). Studies of cytokine expression in HCoV strain 229E-infected monocytes/macrophages are necessary to clarify this point. Following infection of monocytes/macrophages by HCoV strain OC43, viability remained high over 6 days and no apoptosis was observed. The low viral titers were confirmed by demonstration of viral spike antigen on the surface of cells in infected cultures by immunofluorescence microscopy. Lack of apoptosis is likely due to the very poor ability of this virus to infect the cells. Further studies of HCoV-induced apoptosis in monocytes freshly isolated from persons with clinically active MS would be appropriate because monocyte/macrophage activation was observed (acute exacerbation and progressive MS) (9, 19).
I thank Marcel Desrosiers (Human Health Research Centre, INRS-Institut Armand-Frappier) for invaluable help with flow cytometry experiments, Pierre Duquette (MS Clinic, Hôpital Notre-Dame, Montréal, Québec, Canada) and Peter Kinkel (Neurology Department, State University of New York at Buffalo) for help with selecting MS patients, and Pierre Talbot (Laboratory of Neuroimmunovirology, Human Health Research Centre, INRS-Institut Armand-Frappier) for helpful discussions and the generous gift of MAb for immunoassays.
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»